MycRX CEO joining Tempus to discuss real-world data
Dr. Nick Glover will share how RWD informs strategy for their Myc inhibitor program.
Latest MycRX News & Updates
See the latest news and media coverage for MycRX. We track all announcements, press releases, and industry mentions in real time, all in one place.
Developer of Myc oncoprotein inhibitors
mycrxpharma.com- Headquarters
- Austin, United States
- Founded year
- 2013
- Company type
- Private company
- Number of employees
- 2–15
Last updated
Latest news about MycRX
Company announcements
Media coverage
MycRX - 2025 Company Profile, Funding & Competitors - Tracxn
MycRX - Developer of small molecule inhibitors for the treatment of cancer. Raised funding from 2 investors.
Never miss news about MycRX
Track MycRX and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Trending companies
Discover what's making headlines across other trending companies.
United Road
Packed Party
Purpose Legal
Allegrow
Sarah Flint
Green River
System Surveyor
REED
Solu Therapeutics
FreightTrain
Wizard
Ascendant
Fence Supply Inc.
Milam & Greene
SAM
MRP
Greenbridge
Thirteen Lune
EmpowerLocal
Sensorium
WhistlePig
ALM First
Kestrel
Augment
Pegasus
ERG
Hunter Onsite
Tumbleweed Royalty
Supercircle
Silicon Motion
Hamilton
Douglas Emmett